| ADR Ontology |
| ADR Term |
Post viral fatigue syndrome |
| ADR ID |
BADD_A08297 |
| ADR Hierarchy |
|
| Description |
A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9) [MeSH] |
| MedDRA Code |
10057244 |
| MeSH ID |
D015673
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| ME | Myalgic encephalomyelitis | Post viral debility | Post viral fatigue | Post-viral fatigue syndrome | Post-viral fatigue syndrome NOS | Royal Free disease | Post viral fatigue syndrome | Fatigue Syndrome, Chronic | Myalgic Encephalomyelitis | Encephalomyelitis, Myalgic | Chronic Fatigue Syndrome | Chronic Fatigue Syndromes | Fatigue Syndromes, Chronic | Chronic Fatigue-Fibromyalgia Syndrome | Chronic Fatigue Fibromyalgia Syndrome | Chronic Fatigue-Fibromyalgia Syndromes | Fatigue-Fibromyalgia Syndrome, Chronic | Fatigue-Fibromyalgia Syndromes, Chronic | Postviral Fatigue Syndrome | Infectious Mononucleosis-Like Syndrome, Chronic | Infectious Mononucleosis Like Syndrome, Chronic | Royal Free Disease | Chronic Fatigue and Immune Dysfunction Syndrome | Chronic Fatigue Disorder | Chronic Fatigue Disorders | Fatigue Disorder, Chronic | Fatigue Disorders, Chronic | Systemic Exertion Intolerance Disease | Fatigue Syndrome, Postviral | Fatigue Syndromes, Postviral | Postviral Fatigue Syndromes |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D00475 | Citalopram | 0.000083% | | | BADD_D01496 | Montelukast | 0.000208% | |
| The 1th Page 1
Total 1 Pages
|
|
